Are broad product claims slowing down your MedTech product's route to market without you even realising it?

Many MedTech companies assume that regulatory delays mean they need more clinical evidence, more funding, or more time. But in many cases, the real issue is that their product claims are broader than the evidence they already have. In this episode, Hakeem unpacks Jordan Morrison's decision-making framework and explains why narrowing your claims could help you achieve regulatory approval, generate revenue sooner, and build momentum for future growth.

Listeners will discover:

• Why regulatory hurdles aren't always the biggest obstacle to getting your MedTech product to market
• How to match your product claims to the evidence you already have
• Why securing one well-supported claim can accelerate commercialisation and create a platform for future expansion

Play this episode now to discover how a more focused regulatory strategy could help you get your MedTech product to market faster and build commercial momentum.

This keeps the focus where your audience is: commercialising MedTech products, rather than getting lost in the technicalities of regulation.

Book a 30min Healthcare Export Accelerator discovery call

Message me via DM on Linkedin

This podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.